SCHEMBL6187015

SCHEMBL6187015

COc1cccc(OC)c1C(=O)c1c(C)[nH]c2ccc(NC(=O)C3CCC3)cc12

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 4/20 0.49
MTNR1A P48039 2/20 0.49
MTNR1B P49286 2/20 0.49
POLB P06746 2/20 0.47
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
NPSR1 Q6W5P4 1/20 0.45
GRM4 Q14833 1/20 0.43
ITK Q08881 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HTR1A P08908 1/20 0.43
HTR1D P28221 1/20 0.43
HTR1B P28222 1/20 0.43
HTR2C P28335 1/20 0.43
TP53 P04637 2/20 0.42
STK17B O94768 1/20 0.42
STK17A Q9UEE5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6185392 0.98 MAOA (0.49) ULK1MTNR1AMTNR1BPOLBMAOA
SCHEMBL6188508 0.97 MAOA (0.51) ULK1MTNR1AMTNR1BPOLBMAOA
SCHEMBL6188504 0.88 GRM4 (0.51) ULK1MTNR1AMTNR1BPOLBMAOA
SCHEMBL6189495 0.88 PARP1 (0.45) ULK1MTNR1AMTNR1BPOLBMAOA
SCHEMBL6187132 0.88 MAOA (0.50) ULK1POLBMAOAMAOBNPSR1
SCHEMBL6186285 0.87 MAOA (0.49) ULK1POLBMAOAMAOBNPSR1
SCHEMBL6189884 0.86 MAOA (0.48) ULK1POLBMAOAMAOBNPSR1
SCHEMBL6189454 0.85 MAOA (0.53) ULK1POLBMAOAMAOBNPSR1
SCHEMBL6188606 0.85 MAOA (0.55) MAOAMAOBNPSR1ITKSMN1; SMN2
SCHEMBL6185134 0.84 MAOA (0.54) MAOAMAOBNPSR1GRM4ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed